HIF1A and cancer: It was reported that upregulation of HIF1A was associated with increased immune signature, aggressive phenotypes, and worse survival rates in different cancers, and HIF1A expression showed a stronger correlation with immune-inhibiting signatures than with immune-promoting signatures.[31] However, the specific role of HIF1A in different cancer types remains to be further studied.